United States Stem Cell Therapy Market Report & Forecast 2021-2027
Table of Contents1 Introduction to Research & Analysis Reports
1.1 Stem Cell Therapy Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Stem Cell Therapy Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Stem Cell Therapy Overall Market Size
2.1 United States Stem Cell Therapy Market Size: 2021 VS 2027
2.2 United States Stem Cell Therapy Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Stem Cell Therapy Players in United States Market
3.2 Top United States Stem Cell Therapy Companies Ranked by Revenue
3.3 United States Stem Cell Therapy Revenue by Companies
3.4 Top 3 and Top 5 Stem Cell Therapy Companies in United States Market, by Revenue in 2020
3.5 Companies Stem Cell Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Stem Cell Therapy Players in United States Market
3.6.1 List of Tier 1 Stem Cell Therapy Companies in United States
3.6.2 List of Tier 2 and Tier 3 Stem Cell Therapy Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Stem Cell Therapy Market Size Markets, 2021 & 2027
4.1.2 Autologous
4.1.3 Allogeneic
4.2 By Type - United States Stem Cell Therapy Revenue & Forecasts
4.2.1 By Type - United States Stem Cell Therapy Revenue, 2016-2021
4.2.2 By Type - United States Stem Cell Therapy Revenue, 2022-2027
4.2.3 By Type - United States Stem Cell Therapy Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Stem Cell Therapy Market Size, 2021 & 2027
5.1.2 Musculoskeletal Disorder
5.1.3 Wounds & Injuries
5.1.4 Cornea
5.1.5 Cardiovascular Diseases
5.1.6 Others
5.2 By Application - United States Stem Cell Therapy Revenue & Forecasts
5.2.1 By Application - United States Stem Cell Therapy Revenue, 2016-2021
5.2.2 By Application - United States Stem Cell Therapy Revenue, 2022-2027
5.2.3 By Application - United States Stem Cell Therapy Revenue Market Share, 2016-2027
6 Stem Cell Therapy Companies Profiles
6.1 Osiris Therapeutics
6.1.1 Osiris Therapeutics Company Details
6.1.2 Osiris Therapeutics Business Overview
6.1.3 Osiris Therapeutics Stem Cell Therapy Introduction
6.1.4 Osiris Therapeutics Stem Cell Therapy Revenue in United States Market (2016-2021)
6.1.5 Osiris Therapeutics Recent Developments
6.2 NuVasive
6.2.1 NuVasive Company Details
6.2.2 NuVasive Business Overview
6.2.3 NuVasive Stem Cell Therapy Introduction
6.2.4 NuVasive Stem Cell Therapy Revenue in United States Market (2016-2021)
6.2.5 NuVasive Recent Developments
6.3 Chiesi Pharmaceuticals
6.3.1 Chiesi Pharmaceuticals Company Details
6.3.2 Chiesi Pharmaceuticals Business Overview
6.3.3 Chiesi Pharmaceuticals Stem Cell Therapy Introduction
6.3.4 Chiesi Pharmaceuticals Stem Cell Therapy Revenue in United States Market (2016-2021)
6.3.5 Chiesi Pharmaceuticals Recent Developments
6.4 JCR Pharmaceutical
6.4.1 JCR Pharmaceutical Company Details
6.4.2 JCR Pharmaceutical Business Overview
6.4.3 JCR Pharmaceutical Stem Cell Therapy Introduction
6.4.4 JCR Pharmaceutical Stem Cell Therapy Revenue in United States Market (2016-2021)
6.4.5 JCR Pharmaceutical Recent Developments
6.5 Pharmicell
6.5.1 Pharmicell Company Details
6.5.2 Pharmicell Business Overview
6.5.3 Pharmicell Stem Cell Therapy Introduction
6.5.4 Pharmicell Stem Cell Therapy Revenue in United States Market (2016-2021)
6.5.5 Pharmicell Recent Developments
6.6 Medi-post
6.6.1 Medi-post Company Details
6.6.2 Medi-post Business Overview
6.6.3 Medi-post Stem Cell Therapy Introduction
6.6.4 Medi-post Stem Cell Therapy Revenue in United States Market (2016-2021)
6.6.5 Medi-post Recent Developments
6.7 Anterogen
6.7.1 Anterogen Company Details
6.7.2 Anterogen Business Overview
6.7.3 Anterogen Stem Cell Therapy Introduction
6.7.4 Anterogen Stem Cell Therapy Revenue in United States Market (2016-2021)
6.7.5 Anterogen Recent Developments
6.8 Molmed
6.8.1 Molmed Company Details
6.8.2 Molmed Business Overview
6.8.3 Molmed Stem Cell Therapy Introduction
6.8.4 Molmed Stem Cell Therapy Revenue in United States Market (2016-2021)
6.8.5 Molmed Recent Developments
6.9 Takeda (TiGenix)
6.9.1 Takeda (TiGenix) Company Details
6.9.2 Takeda (TiGenix) Business Overview
6.9.3 Takeda (TiGenix) Stem Cell Therapy Introduction
6.9.4 Takeda (TiGenix) Stem Cell Therapy Revenue in United States Market (2016-2021)
6.9.5 Takeda (TiGenix) Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of TablesTable 1. Stem Cell Therapy Market Opportunities & Trends in United States Market
Table 2. Stem Cell Therapy Market Drivers in United States Market
Table 3. Stem Cell Therapy Market Restraints in United States Market
Table 4. Key Players of Stem Cell Therapy in United States Market
Table 5. Top Stem Cell Therapy Players in United States Market, Ranking by Revenue (2019)
Table 6. United States Stem Cell Therapy Revenue by Companies, (US$, Mn), 2016-2021
Table 7. United States Stem Cell Therapy Revenue Share by Companies, 2016-2021
Table 8. Companies Stem Cell Therapy Product Type
Table 9. List of Tier 1 Stem Cell Therapy Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Stem Cell Therapy Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - United States Stem Cell Therapy Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - United States Stem Cell Therapy Revenue (US$, Mn), 2016-2021
Table 13. By Type - United States Stem Cell Therapy Revenue (US$, Mn), 2022-2027
Table 14. By Application - United States Stem Cell Therapy Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - United States Stem Cell Therapy Revenue (US$, Mn), 2016-2021
Table 16. By Application - United States Stem Cell Therapy Revenue (US$, Mn), 2022-2027
Table 17. Osiris Therapeutics Company Details
Table 18. Osiris Therapeutics Business Overview
Table 19. Osiris Therapeutics Stem Cell Therapy Product
Table 20. Osiris Therapeutics Stem Cell Therapy Revenue in United States Market (2016-2021) & (US$ Million)
Table 21. Osiris Therapeutics Recent Developments
Table 22. NuVasive Company Details
Table 23. NuVasive Business Overview
Table 24. NuVasive Stem Cell Therapy Product
Table 25. NuVasive Stem Cell Therapy Revenue in United States Market (2016-2021) & (US$ Million)
Table 26. NuVasive Recent Developments
Table 27. Chiesi Pharmaceuticals Company Details
Table 28. Chiesi Pharmaceuticals Business Overview
Table 29. Chiesi Pharmaceuticals Stem Cell Therapy Product
Table 30. Chiesi Pharmaceuticals Stem Cell Therapy Revenue in United States Market (2016-2021) & (US$ Million)
Table 31. Chiesi Pharmaceuticals Recent Developments
Table 32. JCR Pharmaceutical Company Details
Table 33. JCR Pharmaceutical Business Overview
Table 34. JCR Pharmaceutical Stem Cell Therapy Product
Table 35. JCR Pharmaceutical Stem Cell Therapy Revenue in United States Market (2016-2021) & (US$ Million)
Table 36. JCR Pharmaceutical Recent Developments
Table 37. Pharmicell Company Details
Table 38. Pharmicell Business Overview
Table 39. Pharmicell Stem Cell Therapy Product
Table 40. Pharmicell Stem Cell Therapy Revenue in United States Market (2016-2021) & (US$ Million)
Table 41. Pharmicell Recent Developments
Table 42. Medi-post Company Details
Table 43. Medi-post Business Overview
Table 44. Medi-post Stem Cell Therapy Product
Table 45. Medi-post Stem Cell Therapy Revenue in United States Market (2016-2021) & (US$ Million)
Table 46. Medi-post Recent Developments
Table 47. Anterogen Company Details
Table 48. Anterogen Business Overview
Table 49. Anterogen Stem Cell Therapy Product
Table 50. Anterogen Stem Cell Therapy Revenue in United States Market (2016-2021) & (US$ Million)
Table 51. Anterogen Recent Developments
Table 52. Molmed Company Details
Table 53. Molmed Business Overview
Table 54. Molmed Stem Cell Therapy Product
Table 55. Molmed Stem Cell Therapy Revenue in United States Market (2016-2021) & (US$ Million)
Table 56. Molmed Recent Developments
Table 57. Takeda (TiGenix) Company Details
Table 58. Takeda (TiGenix) Business Overview
Table 59. Takeda (TiGenix) Stem Cell Therapy Product
Table 60. Takeda (TiGenix) Stem Cell Therapy Revenue in United States Market (2016-2021) & (US$ Million)
Table 61. Takeda (TiGenix) Recent Developments
List of FiguresFigure 1. Stem Cell Therapy Segment by Type
Figure 2. Stem Cell Therapy Segment by Application
Figure 3. United States Stem Cell Therapy Market Overview: 2020
Figure 4. United States Stem Cell Therapy Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. United States Stem Cell Therapy Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by Stem Cell Therapy Revenue in 2020
Figure 7. By Type - United States Stem Cell Therapy Revenue Market Share, 2016-2027
Figure 8. By Application - United States Stem Cell Therapy Revenue Market Share, 2016-2027
Figure 9. Osiris Therapeutics Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. NuVasive Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. Chiesi Pharmaceuticals Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. JCR Pharmaceutical Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. Pharmicell Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 14. Medi-post Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 15. Anterogen Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 16. Molmed Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 17. Takeda (TiGenix) Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)